A comparative study of different enzyme immunosorbent assays for human tumor necrosis factor-

Journal of Immunological Methods

Volumn 195, Issue 1-2, 1996, Pages 49-54

  Kreuzer, Karl Anton ^a   Rockstroh, Juergen K ^a   Sauerbruch, Tilman ^a   Spengler, Ulrich ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Detection methodology; ELISA; Human plasma; Tumor necrosis factor

Indexed keywords

AUTOANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030576968     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-1759(96)00090-7     Document Type: Article

References (33)

1. Aarden, L.A., De Groot, E.R., Schaap, O.L. and Lansdorp, P.M. (1987) Production of hybridoma growth factor by human monocytes. Eur. J. Immunol. 17, 1411-1416.
2. Balkwill, F., Burke, F., Talbot, D., Tarvernier, J., Osborne, R., Naylor, S., Durbin, H. and Fiers, W. (1987) Evidence for tumour necrosis factor/cachectin production in cancer. Lancet ii, 1229-1232.
3. Beutler, B.A., Milsark, I.W. and Cerami, A. (1985a) Cachectin/tumor necrosis factor: Production, distribution, and metabolic fate in vivo. J. Immunol. 135, 3972-3977.
4. Beutler, B., Milsark, I.W. and Cerami, A.C. (1985b) Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229, 869-871
5. Bienvenue, J., Coulon, L., Doche, D., Gutowski, M.-C. and Grau, G.E. (1993) Analytical performance of commercial ELISA-kits for IL-2, IL-6 and TNF-α. A WHO study. Eur. Cytokine Netw. 4, 447-451.
6. Cannon, J.C., Nerad, J.L., Poutsiaka, D.D. and Dinarello, C.A. (1993) Measuring circulating cytokines. J. Appl. Physiol. 75, 1897-1902.
7. Carswell, E.A., Old, L.J., Kassel, R.L., Green, S., Fiore, N. and Williamson, B. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl. Acad. Sci. USA 72, 3666-3670.
8. Chatenoud, L., Ferran, A., Reuter, C., Legendre, C., Gevaert, Y., Kreis, H., Franchimont, P. and Bach, J.F. (1989) Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma. New Engl. J. Med. 320, 1420-1421.
9. Diez-Ruiz, A., Tilz, G.P., Zangerle, R., Baier-Bitterlich, G., Wachter, H. and Fuchs, D. (1995) Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur. J. Haematol. 54, 1-8.
10. Engelberts, I., Möller, A., Schoen, G.J.M., van der Linden, C.J. and Buurman, W.A. (1991a) Evaluation of measurement of human TNF in plasma by ELISA. Lymphokine Cytokine Res. 10, 69-76.
11. Engelberts, E., Stephens, S., Francot, G.J.M., van der Linden, C.J. and Buurman, W.A. (1991b) Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338, 515-516.
12. Exley, A.R. and Cohen, J. (1990) Optimal collection of blood samples for the measurement of tumor necrosis factor α. Cytokine 2, 353-356.
13. Ferraiolo, B.L., Moore, J.A., Crase, D. Gribling, P. Wilking, H. and Baughman, R.A. (1988) Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-α in mice. Drug Metab. Dispos. 16, 270-275.
14. Fomsgaard, A., Svenson, M. and Bendtzen, K. (1989) Auto-antibodies to tumor necrosis factor α in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections. Scand. J. Immunol. 30, 219-223.
15. Freeman, R., Wheeler, J., Robertson, H., Paes, M.L. and Laidler, J. (1990) In-vitro production of TNF-α in blood samples. Lancet 336, 312-313.
16. Holobaugh, P.A. and McChesney, D.C. (1990) Effect of anticoagulants and heat on the detection of tumor necrosis factor in murine blood. J. Immunol. Methods. 135, 95-99.
17. Ishihara, K., Hayasaka, K. and Yamazaki, N. (1989) Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan J. Invest. Dermatol. 92, 326S-328S.
18. 2-macroglobulin. Immunol. Today 11, 163-166.
19. Jeffes III, E.B., Ininns, E.K., Schmitz, K.L., Yamamoto, R.S., Dett, C.A. and Granger, G.A. (1989) The presence of antibodies to lymphotoxin and tumor necrosis factor in normal serum. Arthritis Rheum. 32, 1148-1152.
20. Jones, P.D., Shelley, L. and Wakefield, D. (1992) Tumor necrosis factor-α in advanced HIV infection in the absence of AIDS-related secondary infections. J. Acquir. Immune Defic. Syndr. 5, 1266-1271.
21. Lahdevirta, J., Maury, C.P.J., Teppo, A.-M. and Repo H. (1988) Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85, 289-291.
22. McLaughlin, P.J., Davies, H.M. and Aikawa, A. (1990a) Tumour-necrosis factor in normal plasma. Lancet 336, 1014-1015.
23. McLaughlin, P.J., Elwood, N.J., Ramadi, L.T., Pica, M.R. and McKenzie, I.F.C. (1990b) Improvement in sensitivity of enzyme-linked immunosorbent assay for tumour necrosis factor. Immunol. Cell Biol. 68, 51-55.
24. Meager, A., Leung, H. and Woolley, J. (1989) Assays for tumor necrosis factor and related cytokines. J. Immunol. Methods 116, 1-17.
25. Michie, H.R., Manogue, K.R., Spriggs, D.R., Revhaug, A., O'Dwyer, S., Dinarello, C.A., Cerami, A., Wolff, S.M. and Wilmore, D.W. (1988) Detection of circulating tumor necrosis factor after endotoxin administration. New Engl. J. Med. 318, 1481-1486.
26. Ortaldo, J.R., Mason, L.H., Mathieson, B.J., Liang, S.-M., Flick, D.A. and Herberman, R.B. (1986) Mediation of mouse natural cytotoxic activity by tumor necrosis factor. Nature 321, 700-702.
27. Pennica, D., Nedwin G.E., Hayflick, J.S., Seeburg, P.H., Derynck, R., Palladino, M.A., Kohr, W.J., Aggarwal, B.B. and Goeddel, D.V. (1984) Human tumor necrosis factor. Precurser structure, expression and homology to lymphotoxin. Nature 312, 724-729.
28. Riches, P., Gooding, R., Millar, B.C. and Rowbottom, A.W. (1992) Influence of collection and separation of blood samples on plasma IL-I, IL-6 and TNF-α concentrations. J. Immunol. Methods 153, 125-131.
29. Shalaby, M.R., Aggarwal, B.B., Rinderknecht, E., Svedersky, L.P., Finkle, B.S. and Palladino, M.A. (1985) Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J. Immunol. 135, 2069-2073.
30. Spinas, G.A., Keller, U. and Brockhaus, M. (1992) Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. J. Clin. Invest. 90, 533-536.
31. Spofford, B.T., Daynes, R.A. and Granger, G.A. (1974) Cell-mediated immunity in vitro: a highly sensitive assay for human lymphotoxin. J. Immunol. 112, 2111-2116.
32. Thavasu, P.W., Longhurst, S., Joel, S.P., Slevin, M.L. and Balkwill, F.R. (1992) Measuring cytokine levels in blood: Importance of anticoagulants, processing and storage conditions. J. Immunol. 153, 115-124.
33. Tracey, K.J., Wei, H., Manogue, K.R., Fong, Y., Hesse, D.G., Nguyen, H.T., Kuo, G.C., Beutler, B., Cotran, R.S., Cerami, A. and Lowry, S.F. (1988) Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167, 1211-1227.